B
Betta Pharmaceuticals Co Ltd
SZSE:300558
Betta Pharmaceuticals Co Ltd
SZSE:300558
Price:
47.27
CNY
-1.11%
Market Closed
Market Cap:
¥19.9B
Income Statement
Earnings Waterfall
Betta Pharmaceuticals Co Ltd
Betta Pharmaceuticals Co Ltd
Income Statement
Betta Pharmaceuticals Co Ltd
Betta Pharmaceuticals Co Ltd
Currency: CNY
| Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
3
|
0
|
0
|
3
|
3
|
0
|
0
|
9
|
25
|
23
|
31
|
31
|
48
|
52
|
56
|
59
|
40
|
32
|
24
|
17
|
16
|
16
|
22
|
29
|
196
|
211
|
212
|
213
|
55
|
46
|
47
|
44
|
45
|
56
|
0
|
0
|
|
| Revenue |
987
N/A
|
1 035
+5%
|
990
-4%
|
1 015
+3%
|
1 016
+0%
|
1 026
+1%
|
1 081
+5%
|
1 110
+3%
|
1 186
+7%
|
1 224
+3%
|
1 314
+7%
|
1 405
+7%
|
1 540
+10%
|
1 554
+1%
|
1 826
+18%
|
1 744
-5%
|
1 818
+4%
|
1 870
+3%
|
1 842
-2%
|
2 073
+13%
|
2 087
+1%
|
2 246
+8%
|
2 212
-2%
|
2 344
+6%
|
2 184
-7%
|
2 377
+9%
|
2 324
-2%
|
2 437
+5%
|
2 757
+13%
|
2 456
-11%
|
2 660
+8%
|
2 643
-1%
|
2 757
+4%
|
2 892
+5%
|
3 074
+6%
|
3 123
+2%
|
3 265
+5%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(48)
|
(33)
|
(54)
|
(60)
|
(63)
|
(44)
|
(69)
|
(67)
|
(70)
|
(69)
|
(89)
|
(96)
|
(118)
|
(105)
|
(148)
|
(150)
|
(149)
|
(139)
|
(136)
|
(160)
|
(165)
|
(174)
|
(224)
|
(246)
|
(257)
|
(269)
|
(293)
|
(357)
|
(392)
|
(404)
|
(470)
|
(454)
|
(506)
|
(539)
|
(609)
|
(654)
|
(731)
|
|
| Gross Profit |
940
N/A
|
1 002
+7%
|
936
-7%
|
955
+2%
|
953
0%
|
983
+3%
|
1 013
+3%
|
1 042
+3%
|
1 116
+7%
|
1 155
+4%
|
1 226
+6%
|
1 309
+7%
|
1 422
+9%
|
1 449
+2%
|
1 678
+16%
|
1 593
-5%
|
1 669
+5%
|
1 731
+4%
|
1 706
-1%
|
1 913
+12%
|
1 922
+0%
|
2 071
+8%
|
1 988
-4%
|
2 098
+6%
|
1 927
-8%
|
2 108
+9%
|
2 030
-4%
|
2 081
+2%
|
2 365
+14%
|
2 052
-13%
|
2 190
+7%
|
2 189
0%
|
2 251
+3%
|
2 353
+5%
|
2 464
+5%
|
2 469
+0%
|
2 534
+3%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(581)
|
(640)
|
(602)
|
(668)
|
(701)
|
(775)
|
(777)
|
(830)
|
(878)
|
(963)
|
(1 014)
|
(1 086)
|
(1 162)
|
(1 138)
|
(1 268)
|
(1 199)
|
(1 249)
|
(1 282)
|
(1 277)
|
(1 439)
|
(1 481)
|
(1 683)
|
(1 676)
|
(1 888)
|
(1 815)
|
(1 902)
|
(1 904)
|
(1 842)
|
(1 984)
|
(1 725)
|
(1 769)
|
(1 697)
|
(1 777)
|
(1 850)
|
(1 885)
|
(1 965)
|
(1 975)
|
|
| Selling, General & Administrative |
(581)
|
(476)
|
(601)
|
(667)
|
(648)
|
(529)
|
(674)
|
(726)
|
(773)
|
(615)
|
(792)
|
(766)
|
(818)
|
(747)
|
(945)
|
(895)
|
(931)
|
(865)
|
(903)
|
(1 026)
|
(1 039)
|
(1 071)
|
(1 157)
|
(1 309)
|
(1 198)
|
(1 139)
|
(1 183)
|
(1 146)
|
(1 320)
|
(1 022)
|
(1 205)
|
(1 188)
|
(1 273)
|
(1 255)
|
(1 429)
|
(1 480)
|
(1 499)
|
|
| Research & Development |
0
|
(162)
|
0
|
0
|
(57)
|
(203)
|
0
|
0
|
(124)
|
(294)
|
(253)
|
(347)
|
(362)
|
(311)
|
(349)
|
(337)
|
(349)
|
(341)
|
(392)
|
(434)
|
(462)
|
(532)
|
(555)
|
(640)
|
(682)
|
(657)
|
(768)
|
(717)
|
(686)
|
(591)
|
(618)
|
(562)
|
(556)
|
(451)
|
(462)
|
(500)
|
(491)
|
|
| Depreciation & Amortization |
0
|
(2)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(80)
|
0
|
0
|
0
|
(106)
|
0
|
0
|
0
|
(105)
|
0
|
0
|
0
|
(111)
|
0
|
0
|
0
|
(154)
|
0
|
0
|
0
|
(161)
|
0
|
0
|
0
|
(173)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
(0)
|
(1)
|
(0)
|
4
|
(25)
|
(103)
|
(104)
|
19
|
27
|
31
|
27
|
19
|
25
|
27
|
33
|
31
|
28
|
17
|
21
|
20
|
32
|
37
|
61
|
66
|
48
|
47
|
22
|
21
|
49
|
54
|
53
|
53
|
30
|
6
|
15
|
15
|
|
| Operating Income |
358
N/A
|
362
+1%
|
334
-8%
|
287
-14%
|
253
-12%
|
208
-18%
|
236
+13%
|
213
-10%
|
238
+12%
|
193
-19%
|
211
+10%
|
223
+6%
|
260
+16%
|
311
+19%
|
411
+32%
|
395
-4%
|
421
+7%
|
449
+7%
|
429
-5%
|
474
+11%
|
442
-7%
|
389
-12%
|
312
-20%
|
210
-33%
|
112
-47%
|
206
+84%
|
127
-39%
|
239
+88%
|
381
+60%
|
326
-14%
|
422
+29%
|
492
+17%
|
475
-4%
|
503
+6%
|
579
+15%
|
504
-13%
|
559
+11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
6
|
(1)
|
5
|
13
|
17
|
13
|
(47)
|
(61)
|
(73)
|
(12)
|
(17)
|
(17)
|
(17)
|
(44)
|
(45)
|
(50)
|
228
|
(40)
|
263
|
278
|
9
|
15
|
7
|
2
|
(6)
|
(196)
|
(213)
|
(221)
|
(231)
|
(52)
|
(46)
|
(49)
|
(4)
|
(76)
|
(165)
|
(176)
|
(202)
|
|
| Non-Reccuring Items |
0
|
4
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(3)
|
(2)
|
(2)
|
271
|
1
|
0
|
0
|
(8)
|
(0)
|
0
|
0
|
84
|
89
|
88
|
87
|
(6)
|
(2)
|
(6)
|
1
|
(29)
|
1
|
6
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
55
|
59
|
56
|
43
|
42
|
70
|
67
|
66
|
62
|
2
|
(1)
|
(3)
|
(6)
|
(0)
|
(2)
|
(6)
|
(9)
|
(14)
|
(12)
|
(10)
|
(9)
|
(6)
|
(6)
|
(6)
|
(5)
|
(7)
|
25
|
52
|
51
|
53
|
20
|
(8)
|
(9)
|
(5)
|
(4)
|
(2)
|
(2)
|
|
| Pre-Tax Income |
418
N/A
|
425
+1%
|
394
-7%
|
342
-13%
|
311
-9%
|
291
-7%
|
255
-12%
|
217
-15%
|
226
+4%
|
182
-19%
|
193
+6%
|
203
+5%
|
237
+17%
|
267
+12%
|
360
+35%
|
337
-6%
|
639
+89%
|
667
+4%
|
681
+2%
|
742
+9%
|
442
-40%
|
390
-12%
|
313
-20%
|
207
-34%
|
101
-51%
|
88
-13%
|
27
-69%
|
158
+478%
|
289
+83%
|
322
+11%
|
394
+22%
|
430
+9%
|
462
+7%
|
394
-15%
|
410
+4%
|
332
-19%
|
354
+7%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(56)
|
(57)
|
(54)
|
(51)
|
(52)
|
(40)
|
(38)
|
(39)
|
(30)
|
(19)
|
(21)
|
(18)
|
(24)
|
(41)
|
(55)
|
(54)
|
(97)
|
(66)
|
(63)
|
(70)
|
(8)
|
(10)
|
(1)
|
47
|
25
|
37
|
66
|
22
|
41
|
12
|
(14)
|
(22)
|
(17)
|
(7)
|
(21)
|
(30)
|
(69)
|
|
| Income from Continuing Operations |
363
|
368
|
340
|
291
|
259
|
251
|
217
|
178
|
196
|
164
|
172
|
185
|
213
|
226
|
305
|
283
|
541
|
601
|
618
|
672
|
434
|
380
|
312
|
253
|
126
|
125
|
93
|
180
|
330
|
334
|
379
|
408
|
445
|
387
|
389
|
302
|
285
|
|
| Income to Minority Interest |
1
|
1
|
1
|
2
|
5
|
7
|
8
|
9
|
6
|
3
|
4
|
2
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
4
|
7
|
9
|
13
|
21
|
20
|
19
|
17
|
14
|
15
|
16
|
15
|
16
|
16
|
17
|
18
|
|
| Net Income (Common) |
364
N/A
|
369
+1%
|
341
-8%
|
293
-14%
|
264
-10%
|
258
-2%
|
225
-13%
|
187
-17%
|
202
+8%
|
167
-17%
|
176
+5%
|
188
+7%
|
218
+16%
|
231
+6%
|
310
+34%
|
287
-7%
|
546
+90%
|
606
+11%
|
624
+3%
|
678
+9%
|
439
-35%
|
383
-13%
|
319
-17%
|
263
-18%
|
139
-47%
|
145
+5%
|
113
-22%
|
199
+76%
|
347
+75%
|
348
+0%
|
395
+13%
|
424
+7%
|
460
+8%
|
403
-12%
|
405
+0%
|
319
-21%
|
303
-5%
|
|
| EPS (Diluted) |
1.01
N/A
|
1.01
N/A
|
0.85
-16%
|
0.73
-14%
|
0.67
-8%
|
0.64
-4%
|
0.57
-11%
|
0.48
-16%
|
0.51
+6%
|
0.42
-18%
|
0.44
+5%
|
0.47
+7%
|
0.55
+17%
|
0.58
+5%
|
0.78
+34%
|
0.72
-8%
|
1.35
+88%
|
1.49
+10%
|
1.52
+2%
|
1.62
+7%
|
1
-38%
|
0.92
-8%
|
0.75
-18%
|
0.64
-15%
|
0.33
-48%
|
0.35
+6%
|
0.27
-23%
|
0.47
+74%
|
0.82
+74%
|
0.83
+1%
|
0.94
+13%
|
1.01
+7%
|
1.1
+9%
|
0.96
-13%
|
0.97
+1%
|
0.76
-22%
|
0.72
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
